Risk factors and prediction models for moderate to severe hypoproteinemia after hip arthroplasty

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400091635

Enrollment

Unknown

Registered

2024-10-31

Start date

2024-11-01

Completion date

Unknown

Last updated

2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative moderate to severe hypoalbumin

Interventions

Postoperative moderate to severe hypoproteinemia group

Postoperative normal serum group:According to existing studies, hypoproteinemia after hip replacement may be related to preoperative albumin level, blood loss, frailty, operation time

Eligibility

Sex/Gender

All

Age

18 Years to 96 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing total hip arthroplasty/hemihip arthroplasty were included; 2.The clinical data were complete and there were no obvious deficiencies;

Exclusion criteria

Exclusion criteria: 1.History includes bilateral hip fractures, multiple fractures, and multiple trauma; 2.There are diseases that can easily lead to hypoproteinemia: malignant tumors, severe digestive diseases, liver cirrhosis, uremia, etc;

Design outcomes

Primary

Measure	Time frame
Postoperative serum albumin level;	—

Countries

China

Contacts

Public ContactWenGang Zhu

Yuebei People’s Hospital

sggkzwg@163.com+86 751 6913065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026